We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
+$4.1M
Cap. Flow
-$758K
Cap. Flow %
-0.35%
Top 10 Hldgs %
10.99%
Holding
242
New
22
Increased
21
Reduced
29
Closed
23

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$2.67M
2
XOM icon
ExxonMobil
XOM
+$1.63M
3
CRM icon
Salesforce
CRM
+$1.48M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
5
AMZN icon
Amazon
AMZN
+$1.42M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.78M
2
SCHW
Charles Schwab
SCHW
+$1.56M
3
HP icon
Helmerich & Payne
HP
+$1.45M
4
EXPD icon
Expeditors International
EXPD
+$1.34M
5
BKNG icon
Booking.com
BKNG
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 14.4%
3 Healthcare 14.07%
4 Industrials 12.13%
5 Consumer Discretionary 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHK icon
201
Mohawk Industries
MHK
$6.9B
$560K 0.26%
2,950
-1,200
-29% -$234K
TAX
202
DELISTED
Liberty Tax, Inc. Class A
TAX
$553K 0.26%
41,490
– –
VNO icon
203
Vornado Realty Trust
VNO
$7.47B
$537K 0.25%
6,640
– –
GS icon
204
Goldman Sachs
GS
$313B
$519K 0.24%
3,494
– –
NEWS
205
DELISTED
NewStar Financial, Inc.
NEWS
$508K 0.24%
60,304
– –
NRC icon
206
NRC Health Common Stock
NRC
$474M
$489K 0.23%
35,687
– –
OPK icon
207
Opko Health
OPK
$921M
$472K 0.22%
50,537
– –
NKE icon
208
Nike
NKE
$61.9B
$469K 0.22%
8,501
– –
ANET icon
209
Arista Networks
ANET
$219B
$453K 0.21%
+112,576
New +$478K
DD icon
210
DuPont de Nemours
DD
$18.6B
$425K 0.2%
+3,376
New +$444K
CIA icon
211
Citizens
CIA
$245M
$298K 0.14%
39,211
– –
IRWD icon
212
Ironwood Pharmaceuticals
IRWD
$611M
$270K 0.13%
24,651
– –
SAGE
213
DELISTED
Sage Therapeutics
SAGE
$234K 0.11%
7,768
– –
ACOR
214
DELISTED
Acorda Therapeutics
ACOR
$230K 0.11%
75
– –
UA icon
215
Under Armour Class C
UA
$2.92B
$204K 0.1%
+5,608
New +$207K
GOOGL icon
216
Alphabet (Google) Class A
GOOGL
$3.91T
$194K 0.09%
5,520
– –
SGMO
217
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$136K 0.06%
23,413
– –
ZDGE icon
218
Zedge
ZDGE
$38.9M
$91K 0.04%
+19,825
New +$83K
KPTI icon
219
Karyopharm Therapeutics
KPTI
$168M
$78K 0.04%
777
– –
ABBV icon
220
AbbVie
ABBV
$458B
– –
-9,454
Closed -$540K
ADI icon
221
Analog Devices
ADI
$181B
– –
-18,615
Closed -$1.1M
BKNG icon
222
Booking.com
BKNG
$138B
– –
-25,225
Closed -$1.3M
DVN icon
223
Devon Energy
DVN
$51.9B
– –
-16,840
Closed -$462K
EQR icon
224
Equity Residential
EQR
$25.4B
– –
-6,777
Closed -$508K
EXPD icon
225
Expeditors International
EXPD
$22.9B
– –
-27,503
Closed -$1.34M
6 7 8
9
10

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $247M AUM 30.07% 1-Year Est. Return
AAG
Avalon Advisory Group Wexford, Pennsylvania $248M AUM 11.89% 1-Year Est. Return

Capital Impact Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Capital Impact Advisors held 242 positions worth $214M, up 2% from $210M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Capital Impact Advisors's Q2 2016 filing shows 22 new, 21 increased, 29 reduced and 23 closed positions. Its largest new stake was ExxonMobil: 18,463 shares worth $1.73M. The largest sale was Jazz Pharmaceuticals, an estimated $1.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Capital Impact Advisors's largest Q2 2016 buy was ExxonMobil: 18,463 shares worth $1.73M.
  • Capital Impact Advisors added most to United Therapeutics in Q2 2016, an estimated $2.67M increase.
  • Capital Impact Advisors's biggest Q2 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $1.78M.
  • Capital Impact Advisors fully exited Charles Schwab in Q2 2016, selling an estimated $1.56M.
  • Capital Impact Advisors's ten largest holdings make up 11% of its $214M portfolio in Q2 2016.
  • Capital Impact Advisors opened 22 new positions and closed 23 in Q2 2016.
  • Capital Impact Advisors's portfolio value rose 2% quarter-over-quarter to $214M.

Based on Capital Impact Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.